Teva Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	33,115	35,886	24,971	11,703	10,132	8,835
Market Cap Growth	90.14%	43.71%	113.37%	15.50%	14.68%	-16.46%
Enterprise Value	46,363	49,428	40,097	29,250	29,686	31,095
Last Close Price	28.80	31.21	22.04	10.44	9.12	8.01
PE Ratio	23.78	25.79	-15.20	-20.88	-4.15	21.08
Forward PE	10.72	12.07	8.35	4.21	3.63	3.02
PEG Ratio	4.18	1.82	6.69	0.40	1.63	0.68
PS Ratio	1.89	2.08	1.51	0.74	0.68	0.56
PB Ratio	4.18	4.54	4.65	1.56	1.30	0.86
P/TBV Ratio	4.23	4.59	4.64	1.56	1.30	0.86
P/FCF Ratio	28.47	31.26	33.34	13.90	9.72	37.44
P/OCF Ratio	19.82	21.76	20.03	8.56	6.37	11.07
EV/Sales Ratio	2.69	2.86	2.42	1.85	1.99	1.96
EV/EBITDA Ratio	9.36	15.65	53.04	18.44	-33.39	10.21
EV/EBIT Ratio	11.73	22.92	-132.33	67.55	-13.51	18.12
EV/FCF Ratio	40.39	43.06	53.53	34.74	28.49	131.76
Debt / Equity Ratio	2.16	2.16	3.16	2.48	2.51	2.09
Debt / EBITDA Ratio	5.41	5.41	23.91	12.71	-24.25	7.70
Debt / FCF Ratio	14.89	14.89	24.14	23.94	20.69	99.40
Net Debt / Equity Ratio	1.71	1.71	2.75	2.26	2.40	2.07
Net Debt / EBITDA Ratio	4.29	4.29	19.55	10.67	-21.10	6.99
Net Debt / FCF Ratio	11.79	11.79	19.73	20.10	18.00	90.23
Asset Turnover	0.43	0.43	0.40	0.36	0.33	0.32
Inventory Turnover	2.69	2.69	2.41	2.09	2.08	2.02
Quick Ratio	0.54	0.54	0.50	0.54	0.57	0.61
Current Ratio	1.04	1.04	0.98	1.02	1.05	1.14
Return on Equity (ROE)	20.80%	20.80%	-28.30%	-7.36%	-25.19%	4.09%
Return on Assets (ROA)	6.18%	6.18%	-1.12%	0.98%	-3.82%	2.37%
Return on Invested Capital (ROIC)	8.03%	8.03%	-1.43%	1.21%	-4.51%	2.73%
Return on Capital Employed (ROCE)	8.02%	8.02%	-1.05%	1.36%	-6.35%	4.63%
Earnings Yield	4.31%	3.88%	-6.58%	-4.79%	-24.12%	4.74%
FCF Yield	3.51%	3.20%	3.00%	7.19%	10.28%	2.67%

Updated Jan 28, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q